{{Rsnum
|rsid=1509269
|Chromosome=4
|position=137832570
|Orientation=plus
|GMAF=0.09458
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 80.0 | 18.5 | 1.5
| HCB | 88.9 | 11.1 | 0.0
| JPT | 93.2 | 6.8 | 0.0
| YRI | 81.0 | 17.5 | 1.6
| ASW | 0.0 | 0.0 | 0.0
| CHB | 88.9 | 11.1 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}

rs1509269 increases susceptibility to Parkinson's disease 1.71 times for carriers of the C allele {{PMID|16252231|OA=1
}}

{{PMID Auto
|PMID=16685661
|Title=Genomewide association, Parkinson disease, and PARK10.
|OA=1
}}

{{PMID Auto
|PMID=16685662
|Title=No evidence for association with Parkinson disease for 13 single-nucleotide polymorphisms identified by whole-genome association screening.
|OA=1
}}

{{PMID Auto
|PMID=16685663
|Title=A case-control association study of the 12 single-nucleotide polymorphisms implicated in Parkinson disease by a recent genome scan.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}